Alzheimer's disease risk gene CD2AP is a dose-sensitive determinant of synaptic structure and plasticity

Pavešković, M., De-Paula, R. B., Ojelade, S. A., Tantry, E. K., Kochukov, M. Y., Bao, S., Veeraragavan, S., Garza, A. R., Srivastava, S., Song, S.-Y., Fujita, M., Duong, D. M., Bennett, D. A., De Jager, P. L., Seyfried, N. T., Dickinson, M. E., Heaney, J. D., Arenkiel, B. R., & Shulman, J. M. (2024). Alzheimer’s disease risk gene CD2AP is a dose-sensitive determinant of synaptic structure and plasticity. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddae115
Authors:
Matea Pavešković
Ruth B De-Paula
Shamsideen A Ojelade
Evelyne K Tantry
Mikhail Y Kochukov
Suyang Bao
Surabi Veeraragavan
Alexandra R Garza
Snigdha Srivastava
Si-Yuan Song
Masashi Fujita
Duc M Duong
David A Bennett
Philip L De Jager
Nicholas T Seyfried
Mary E Dickinson
Jason D Heaney
Benjamin R Arenkiel
Joshua M Shulman
Affiliated Authors:
Masashi Fujita
Philip L De Jager
Author Keywords:
alzheimer’s disease
apolipoproteins
cd2ap
endocytosis
haploinsufficiency
lipid metabolism
plasticity
proteomics
proteostasis
synapse
alzheimer's disease
Publication Type:
Article
Unique ID:
10.1093/hmg/ddae115
PMID:
Publication Date:
Data Source:
PubMed

Record Created: